SZSE:301211 (China)
Â
Class A
Â¥
19.73
(+1.08%)
Nov 28
Business Description
Hubei Biocause Heilen Pharmaceutical Co Ltd
ISIN : CNE100005782
Share Class Description:
SZSE:301211: Class ACompare
Compare
Traded in other countries / regions
301211.China IPO Date
2021-12-22Description
Hubei Biocause Heilen Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and preparation products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 309.64 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-EBITDA | 0.05 | |||||
| Interest Coverage | 155.93 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 26.92 | |||||
| Beneish M-Score | -2.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.7 | |||||
| 3-Year EBITDA Growth Rate | -8.3 | |||||
| 3-Year EPS without NRI Growth Rate | -8.8 | |||||
| 3-Year Book Growth Rate | 36.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.92 | |||||
| 9-Day RSI | 44.7 | |||||
| 14-Day RSI | 48.94 | |||||
| 6-1 Month Momentum % | 25.66 | |||||
| 12-1 Month Momentum % | -17.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 14.62 | |||||
| Quick Ratio | 13.41 | |||||
| Cash Ratio | 12.6 | |||||
| Days Inventory | 191.67 | |||||
| Days Sales Outstanding | 53.35 | |||||
| Days Payable | 111.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.46 | |||||
| Dividend Payout Ratio | 1.49 | |||||
| Forward Dividend Yield % | 2.46 | |||||
| 5-Year Yield-on-Cost % | 2.46 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 2.31 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 32.18 | |||||
| Operating Margin % | 9.85 | |||||
| Net Margin % | 23.38 | |||||
| FCF Margin % | -22.98 | |||||
| ROE % | 4.56 | |||||
| ROA % | 4.27 | |||||
| ROIC % | 6.59 | |||||
| ROC (Joel Greenblatt) % | 23.25 | |||||
| ROCE % | 4.9 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 53.32 | |||||
| PE Ratio without NRI | 61.08 | |||||
| Price-to-Owner-Earnings | 481.23 | |||||
| PS Ratio | 12.48 | |||||
| PB Ratio | 2.48 | |||||
| Price-to-Tangible-Book | 2.55 | |||||
| Price-to-Operating-Cash-Flow | 55.11 | |||||
| EV-to-EBIT | 34.9 | |||||
| EV-to-EBITDA | 34.9 | |||||
| EV-to-Revenue | 8.82 | |||||
| EV-to-FCF | -42.44 | |||||
| Price-to-Graham-Number | 2.63 | |||||
| Price-to-Net-Current-Asset-Value | 3.28 | |||||
| Price-to-Net-Cash | 3.85 | |||||
| Earnings Yield (Greenblatt) % | 2.87 | |||||
| FCF Yield % | -1.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hubei Biocause Heilen Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 454.574 | ||
| EPS (TTM) (Â¥) | 0.37 | ||
| Beta | 0 | ||
| Volatility % | 46.56 | ||
| 14-Day RSI | 48.94 | ||
| 14-Day ATR (Â¥) | 1.176387 | ||
| 20-Day SMA (Â¥) | 21 | ||
| 12-1 Month Momentum % | -17.16 | ||
| 52-Week Range (Â¥) | 13.63 - 25.96 | ||
| Shares Outstanding (Mil) | 288 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hubei Biocause Heilen Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hubei Biocause Heilen Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hubei Biocause Heilen Pharmaceutical Co Ltd Frequently Asked Questions
What is Hubei Biocause Heilen Pharmaceutical Co Ltd(SZSE:301211)'s stock price today?
The current price of SZSE:301211 is ¥19.73. The 52 week high of SZSE:301211 is ¥25.96 and 52 week low is ¥13.63.
When is next earnings date of Hubei Biocause Heilen Pharmaceutical Co Ltd(SZSE:301211)?
The next earnings date of Hubei Biocause Heilen Pharmaceutical Co Ltd(SZSE:301211) is .
Does Hubei Biocause Heilen Pharmaceutical Co Ltd(SZSE:301211) pay dividends? If so, how much?
The Dividend Yield %  of Hubei Biocause Heilen Pharmaceutical Co Ltd(SZSE:301211) is 2.46% (As of Today), Highest Dividend Payout Ratio of Hubei Biocause Heilen Pharmaceutical Co Ltd(SZSE:301211) was 1.49. The lowest was 0.6. And the median was 0.64. The  Forward Dividend Yield % of Hubei Biocause Heilen Pharmaceutical Co Ltd(SZSE:301211) is 2.46%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers